NasdaqGS - Nasdaq Real Time Price USD

Nautilus Biotechnology, Inc. (NAUT)

0.8816
-0.0454
(-4.90%)
At close: May 14 at 4:00:01 PM EDT
0.8741
-0.01
(-0.85%)
After hours: May 14 at 5:37:05 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
78,713
81,476
76,152
63,618
50,498
Operating Income
-78,713
-81,476
-76,152
-63,618
-50,498
Net Non Operating Interest Income Expense
10,134
10,780
12,550
5,816
329
Other Income Expense
--
-84
-73
-122
-146
Pretax Income
-68,663
-70,780
-63,675
-57,924
-50,315
Net Income Common Stockholders
-68,663
-70,780
-63,675
-57,924
-50,315
Diluted NI Available to Com Stockholders
-68,663
-70,780
-63,675
-57,924
-50,315
Basic EPS
-0.56
--
-0.51
-0.46
-0.60
Diluted EPS
-0.56
--
-0.51
-0.46
-0.60
Basic Average Shares
125,426.5090
--
124,919.1440
124,589.5550
84,464.0810
Diluted Average Shares
125,426.5090
--
124,919.1440
124,589.5550
84,464.0810
Total Expenses
78,713
81,476
76,152
63,618
50,498
Net Income from Continuing & Discontinued Operation
-68,663
-70,780
-63,675
-57,924
-50,315
Normalized Income
-68,663
-70,780
-63,675
-57,924
-50,315
Interest Income
10,134
10,780
12,550
5,816
329
Net Interest Income
10,134
10,780
12,550
5,816
329
EBIT
-78,713
-81,476
-76,152
-63,618
-50,498
EBITDA
-72,326
-75,123
-70,447
-60,202
-47,656
Reconciled Depreciation
6,387
6,353
5,705
3,416
2,842
Net Income from Continuing Operation Net Minority Interest
-68,663
-70,780
-63,675
-57,924
-50,315
Normalized EBITDA
-72,326
-75,123
-70,447
-60,202
-47,656
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 8/7/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SEER Seer, Inc.
2.1100
+9.90%
 
LYEL Lyell Immunopharma, Inc.
0.3900
-3.61%
 
DNTH Dianthus Therapeutics, Inc.
18.90
+0.32%
 
LENZ LENZ Therapeutics, Inc.
27.63
-4.59%
 
LYRA Lyra Therapeutics, Inc.
0.1117
+18.33%
 
IPSC Century Therapeutics, Inc.
0.4891
-7.02%
 
ALEC Alector, Inc.
1.0700
-3.60%
 
IBO Impact BioMedical Inc.
0.5205
-5.23%
 
PCSA Processa Pharmaceuticals, Inc.
0.2340
+2.09%
 
STRO Sutro Biopharma, Inc.
0.7330
-10.07%